ArticleBMC microbiology2025
Multidrug-resistant E. Coli in wastewater sources: a comparative study and identification of resistance hotspots.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Antibiotic resistance genes in companion animals and humans driven by the gut microbial communities: composition, distribution, and implications.BMC veterinary research · 2026Article
- Exploring the Antibacterial Properties of a Newly Isolated Microviridae Phage Against Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- Coliform Load and Antimicrobial Resistance in Ghana's Seafood Processing Effluent (2021-2024): Evidence of Operational Improvement and Persistent AMR Risk.Life (Basel, Switzerland) · 2026Article
- Widespread Distribution of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis work aims to study the patterns of resistance to antibiotics in wastewater samples collected from hospitals, the community, and the wastewater treatment plant using the indicator bacterium Escherichia coli. In addition, studying the phylogenetic type and screening for beta-lactamase-producing and diarrhoeagenic E. coli.
methodsThe isolates were subjected to antibiotic sensitivity tests using the Kirby-Bauer disc diffusion method using 11 antibiotics. Conventional PCR was performed for the detection of E. coli that produces beta-lactamase, as well as for the phylogenetic typing of isolates and to detect diarrheagenic strains.
resultsFrom 120 wastewater samples, 92 E. coli strains were recovered and among them 66.3% were resistant. The highest resistance of isolates was observed in ampicillin/sulbactam with a moderately high rate of 37%, while the lowest resistance was reported in gentamycin at a low rate of 3.3%. Hospital wastewater isolates (HW) (75%) were more resistant than community wastewater isolates (CW) (50%). A high rate of resistance was reported in tetracycline (46.9%) among the hospital wastewater isolates, while a moderate rate of resistance was detected among community wastewater isolates to aztreonam (22.2%), making them the least effective antibiotics in these groups. More resistant isolates were found in WWTP influent (83.3%) than in effluent (44.4%). However, effluent isolates showed higher resistance to certain antibiotics, including cefepime (11.1% vs. 8.3%), piperacillin/tazobactam (11.1% vs. 4.2%), and imipenem (5.6% vs. 4.2%), than the influent. E. coli strains that showed MDR phenotype were 42.6% of resistant strains, with higher prevalence among HW (50%) and WWTPs influent (45%) than WWTPs effluent (37.5%) and CW (22.2%). Although resistance to Access antibiotics was the highest across all sources, it was comparable to the resistance observed for Watch antibiotics. At least one of the tested beta-lactamase genes was detected in 67.39% of beta-lactam-resistant E. coli strains, with bla
conclusionEven though resistance was less in community wastewater than hospital wastewater, community outlets might be a source of spreading resistance. Furthermore, wastewater treatment might not be enough to eliminate resistant bacteria from the effluent; as a result, the effluent quality should be continuously monitored and evaluated.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.